Latest Articles

Publication Date
Breakthrough: New Cancer Drug Ampligen Delivers Promising Results in Pancreatic, Ovarian, and Breast Cancer Trials - Stock Titan

Breakthrough: New Cancer Drug Ampligen Delivers Promising Results in Pancreatic, Ovarian, and Breast Cancer Trials Stock Titan

Published: Aug. 6, 2025, 1 p.m.
7 Dividend Stocks for 2025 — Some Pay Over 8%, Some Just Refuse to Die - The Globe and Mail

7 Dividend Stocks for 2025 — Some Pay Over 8%, Some Just Refuse to Die The Globe and Mail

Published: Aug. 6, 2025, 12:57 p.m.
MyHealthTeam Now Hosts 11 Communities for People Living with Cancer - StreetInsider

MyHealthTeam Now Hosts 11 Communities for People Living with Cancer StreetInsider

Published: Aug. 6, 2025, 12:25 p.m.
Cartherics unveils cleanroom facility for cell therapy manufacturing - Med-Tech Insights

Cartherics unveils cleanroom facility for cell therapy manufacturing Med-Tech Insights

Published: Aug. 6, 2025, 12:25 p.m.
MyHealthTeam Now Hosts 11 Communities for People Living with Cancer - Morningstar

MyHealthTeam Now Hosts 11 Communities for People Living with Cancer Morningstar

Published: Aug. 6, 2025, 12:23 p.m.
First immunotherapy combination for endometrial cancer approved by NICE - Oncology Central

First immunotherapy combination for endometrial cancer approved by NICE Oncology Central

Published: Aug. 6, 2025, 11:18 a.m.
Watching Your Estrogen Levels? 5 Foods You May Want To Avoid or Limit - health.com

Watching Your Estrogen Levels? 5 Foods You May Want To Avoid or Limit health.com

Published: Aug. 6, 2025, 11:13 a.m.
New NHS Drug Option for Advanced Endometrial Cancer - Medscape

New NHS Drug Option for Advanced Endometrial Cancer Medscape

Published: Aug. 6, 2025, 10:54 a.m.
Building resilient economies begins with healthy women - Bizcommunity

Building resilient economies begins with healthy women Bizcommunity

Published: Aug. 6, 2025, 10:25 a.m.
NICE Recommends Keytruda Combination for First-Line Treatment of Advanced Endometrial Cancer - NAVLIN DAILY

NICE Recommends Keytruda Combination for First-Line Treatment of Advanced Endometrial Cancer NAVLIN DAILY

Published: Aug. 6, 2025, 9:30 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!